Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Operating Expenses | 24,599 | 23,757 | 46,568 | 59,753 | 61,998 |
| Operating Income | -24,599 | -23,757 | -46,568 | -59,753 | -61,998 |
| Other Income | -30,219 | -495 | 109 | 79 | 0 |
| Pre-tax Income | -54,818 | -24,252 | -46,459 | -59,674 | -61,998 |
| Income Tax | N/A | -438 | N/A | N/A | N/A |
| Net Income Continuous | -54,818 | -23,814 | -46,459 | -59,674 | -61,998 |
| Net Income | $-54,818 | $-23,814 | $-46,459 | $-59,674 | $-61,998 |
| EPS Basic Total Ops | -21.11 | -23.69 | -56.82 | -113.34 | N/A |
| EPS Basic Continuous Ops | -21.11 | -23.71 | -56.78 | -113.28 | N/A |
| EPS Diluted Total Ops | -21.11 | -23.69 | -56.82 | -113.34 | N/A |
| EPS Diluted Continuous Ops | -21.11 | -23.71 | -56.78 | -113.28 | N/A |
| EPS Diluted Before Non-Recurring Items | -13.49 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-24,232 | $-23,323 | $-46,146 | $-59,365 | $-61,569 |